132 related articles for article (PubMed ID: 34762167)
1. Complications, treatments, and visual prognosis of choroidal osteomas.
Seong HJ; Kim YJ; Choi EY; Lee J; Byeon SH; Kim SS; Koh HJ; Lee SC; Lee CS
Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1713-1721. PubMed ID: 34762167
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study.
Furino C; Di Antonio L; Grassi MO; Rispoli M; Reibaldi M; Niro A; Alessio G
Eur J Ophthalmol; 2019 May; 29(3):323-329. PubMed ID: 30101614
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
[TBL] [Abstract][Full Text] [Related]
4. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
5. Etiology, Treatment Patterns, and Outcomes for Choroidal Neovascularization in the Pediatric Population: An Intelligent Research in Sight (IRIS®) Registry Study.
Finn AP; Fujino D; Lum F; Rao P
Ophthalmol Retina; 2022 Feb; 6(2):130-138. PubMed ID: 34091079
[TBL] [Abstract][Full Text] [Related]
6. Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma.
Szelog JT; Bonini Filho MA; Lally DR; de Carlo TE; Duker JS
Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):69-72. PubMed ID: 26731212
[TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
[TBL] [Abstract][Full Text] [Related]
8. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
Cheng Y; Li Y; Huang X; Qu Y
Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
[TBL] [Abstract][Full Text] [Related]
9. Predicting Visual Outcomes in Choroidal Osteoma Treated with Anti-vascular Endothelial Growth Factor.
Kang HG; Kim TY; Lee J; Byeon SH; Kim SS; Kim M
Am J Ophthalmol; 2022 Dec; 244():143-151. PubMed ID: 35970208
[TBL] [Abstract][Full Text] [Related]
10. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
Steinle NC; Du W; Gibson A; Saroj N
Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.
Jang JH; Kim KH; Lee SJ; Park JM
Korean J Ophthalmol; 2012 Dec; 26(6):478-80. PubMed ID: 23204807
[TBL] [Abstract][Full Text] [Related]
13. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
14. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
Ahmadieh H; Vafi N
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
[TBL] [Abstract][Full Text] [Related]
15. DEVELOPMENT OF CHOROIDAL NEOVASCULARIZATION AFTER TREATMENT WITH PHOTODYNAMIC THERAPY IN A 5-YEAR-OLD FEMALE WITH CHOROIDAL OSTEOMA.
Jabbehdari S; Fernández-Vega Gonzalez A; Zahid S; Mieler WF
Retin Cases Brief Rep; 2022 Nov; 16(6):799-801. PubMed ID: 33229919
[TBL] [Abstract][Full Text] [Related]
16. Choroidal naevi complicated by choroidal neovascular membrane and outer retinal tubulation.
Papastefanou VP; Nogueira V; Hay G; Andrews RM; Harris M; Cohen VM; Sagoo MS
Br J Ophthalmol; 2013 Aug; 97(8):1014-9. PubMed ID: 23686326
[TBL] [Abstract][Full Text] [Related]
17. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
Yang HS; Kim JG; Kim JT; Joe SG
Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
20. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
Shin JY; Kwon KY; Byeon SH
Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]